en
E-mail us
Mol2Med™ First-Time-Right 3-STEP Approach

Crystal Pharmatech are a specialized CRO/CDMO focused on Solid State Research, Pre-Formulation, Formulation Development and Manufacturing.  Our strength is our focus and expertise in these specialties and the outcome for the client is the following Mol2Med™ Integrated Services: First-Time-Right 3-STEP Approach, designed to expedite small molecule lead compounds or preclinical candidates into Phase I and beyond, with unparalleled efficiency and precision. This First-Time-Right 3-step approach begins at the lead optimization/PCC stage:First-Time-Right_Direct_Route_to_FIH.png


Step 1: Developability Assessment


Step 2: Solid Form Screening/Selection and Pre-Formulation


Step 3: Formulation Development and CTM Manufacturing


This innovative approach guarantees a robust API form and a scalable manufacturing process, culminating in a First-Time-Right formulation for Phase I. Streamlining the transition to future clinical studies upon Phase I success, our First-Time-Right approach sets the foundation for optimized drug development and success beyond.

Achieve Your Success with Our Expertise
Contact Us
bd_global@crystalpharmatech.com +1-609-604-8303
U.S
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
Suite B4-101, Biobay, 218 Xinghu Street, Suzhou Industrial Park, Suzhou, China, 215123
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
bd_global@crystalpharmatech.com +1-609-604-8303